Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications [PMID: 40261091] Laboratory literature summary: Semaglutide and GLP-1 Agonists: Forensic and Medicolegal Implications
Ingredient Disclosure: At the time of publication, the ingredient list displayed on the official product page included water, glycerin, peony root extract, and mineral oil
All five trials met the primary objective of excluding an increased risk of cardiovascular disease in patients treated with DPP-4 inhibitors, however, none were associated with any cardiovascular benefit (7375)
Understanding the realistic timeline prevents this costly mistake
For longer trips where refrigeration is genuinely unavailable, you are relying on the room-temperature stability window
doi: 10.1016/S0140-6736(09)61457-4 19 de SilvaVASuraweeraCRatnatungaSSDayabandaraMWanniarachchiNHanwellaR